Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003110267 | SCV003780077 | uncertain significance | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A | 2022-09-27 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 199 of the MOCS1 protein (p.Val199Ile). This variant is present in population databases (rs377241570, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with MOCS1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV003110267 | SCV005668673 | uncertain significance | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A | 2024-03-11 | criteria provided, single submitter | clinical testing |